Torsten Mau

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach.

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria.

Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties.

Ekosem-Agrar AG is a holding company, with interests in the the production and processing of animal and vegetable agricultural products. Its products includes diary and diary related products, agriculture, seed production and breeding, suckler cow husbandry and organic agriculture. The firm grows grain, potatoes, peas, sunflowers, sugar beets, soybeans, fodder, and other crops. The company was founded by Stefan Dürr in 1994 and is headquartered in Walldorf, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health China Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler, Martin Schwarz. The German company was founded in 2019.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health Japan Holding GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Frank Hübler, Martin Schwarz.

BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Vetmedica GmbH is a German company dedicated to the research and development of products related to animal health. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Dana Leskova, Stephan Günther Dolle.

Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Ehrmann AG manufactures and distributes dairy products. It offers almighurt, grand dessert, orchard, dreams, lacto zero, and natural products. The company was founded by Alois Ehrmann in 1920 and is headquartered in Oberschönegg, Germany.

Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

Cobepa SA is an investment holding Belgian company. The company is based in Brussels, Belgium. The company was founded in 1957. The CEO is Jean-Marie Laurent Josi.

Part of Profunda Verwaltungs GmbH & Co. KG, the German company provides asset management services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Hubertus von Baumbach, Christoph Gauger.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Europe GmbH is a German company that manufactures basic pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler and Martin Schwarz. The company was founded in 1990.